Yi-Bin Chen, MD

Yi-Bin Chen, MD is the Director of the Hematopoietic Cell Transplant and Cell Therapy Program at Massachusetts General Hospital. Yi-Bin is the inaugural Allan Rogers, Jr. and Cara J. Rogers Endowed Chair and an Associate Professor at Harvard Medical School. He has spent his career in clinical investigation with the goal of improving outcomes for patients undergoing hematopoietic cell transplantation. Yi-Bin has led early pilot and Phase 1 efforts through pivotal international Phase 3 trials in almost all aspects of transplantation. Most recently, he has focused on novel agents for the prevention and treatment of graft-vs-host disease (GVHD) as well as the incorporation of maintenance therapies after transplantation to prevent disease relapse.